$DRIO

$3.48 +$0.08 (2.35%) Close

$DRIO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 9.8M shares outstanding

Who owns DRIO?

By type of holder

Institutions 8.7% Insiders 11.9% Everyone else 79.4%

Concentration Top 10 holders own 18.1%

Nantahala Capital Management, LLC 6.2% · Raphael Erez 4.6%

Institutional ownership

8.7%

+0.1 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

+14.1K

by institutions in Q2 2026

New / sold out

2 / 2

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +19.0K
Vanguard Fiduciary Trust Co +7.3K

Biggest sellers in Q2 2026

UBS Group AG −15.8K
Geode Capital Management, LLC −3.8K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for DarioHealth Corp in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+62.4%

+62.44% a year

Each share's claim on the business

−38.4%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $46K

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years95% 3–5 years0% 1–3 years0% Under 1 year5%

Quarterly turnover

3.2%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting DRIO on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
NC Nantahala Capital Management, LLC	610.7K	6.23%	+1 (+0.0%)	≤2021	0.1%
Shares held by quarter Peak holding2.5M (Q3'24) Change over 8 quarters−1.9M Share of the company6.230% Nantahala Capital Management, LLC's full portfolio →
VC Vanguard Capital Management LLC	65.7K	0.67%	−235 (−0.4%)	≤2021	0.0%
Shares held by quarter Peak holding65.9K (Q1'26) Change over 8 quarters+65.7K Share of the company0.670% Vanguard Capital Management LLC's full portfolio →

Nantahala Capital Management, LLC

610.7K

% of company

6.23%

Change vs last qtr

+1 (+0.0%)

Held since

≤2021

Vanguard Capital Management LLC

65.7K

% of company

0.67%

Change vs last qtr

−235 (−0.4%)

Held since

≤2021

21 more super investors behind a free account

See every manager holding DarioHealth Corp, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting DRIO on Form N-PORT; together they hold 1.4% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$433K	65.7K	0.67%	0.00%	June 30, 2026
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$236K	32.1K	0.33%	0.00%	August 31, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$433K

% of company

0.67%

% of the fund

0.00%

As of

June 30, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$236K

% of company

0.33%

% of the fund

0.00%

As of

August 31, 2026

10 more funds behind a free account

See every fund holding DarioHealth Corp and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
RE Raphael Erez Insider	454.7K	4.64%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company4.640% Raphael Erez's insider activity →
FC Franco-Yehuda Chen Insider	125.0K	1.28%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.280% Franco-Yehuda Chen's insider activity →

Raphael Erez

Insider

454.7K

% of company

4.64%

Change vs last qtr

—

Held since

—

Franco-Yehuda Chen

Insider

125.0K

% of company

1.28%

Change vs last qtr

—

Held since

—

10 more holders behind a free account

See every insider and 5%+ holder of DarioHealth Corp.

Comments